# Sedation During Noninvasive Ventilation (NIV)

> **NCT02264626** · NA · UNKNOWN · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 15 (estimated)

## Conditions studied

- Acute Hypercapnic Respiratory Failure

## Interventions

- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT02264626
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2016-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02264626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02264626, "Sedation During Noninvasive Ventilation (NIV)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02264626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*